The global Oncolytic Virus Therapy market is projected to grow from US$ 8 million in 2024 to US$ 29 million by 2030, at a Compound Annual Growth Rate (CAGR) of 24.9% during the forecast period.

Oncolytic Virus Therapy Market

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

Market Analysis and Insights: Global Oncolytic Virus Therapy Market

Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.

North America and Europe are the main markets, each accounting for about 40% of the market.

Report Covers:

This report presents an overview of global market for Oncolytic Virus Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Oncolytic Virus Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Oncolytic Virus Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oncolytic Virus Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Oncolytic Virus Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Oncolytic Virus Therapy revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Oncolytic Virus Therapy Market Report

Report Metric	Details
Report Name	Oncolytic Virus Therapy Market
Accounted market size in 2024	US$ 8 in million
Forecasted market size in 2030	US$ 29 million
CAGR	24.9
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	HSV-based Oncolytic Viruses Adenoviruses-based Oncolytic Viruses Vaccinia Virus-based Oncolytic Viruses Vesicular Stomatitis Virus-based Oncolytic Viruses Newcastle Disease Virus-based Oncolytic Viruses
Segment by Application	Melanoma Prostate Cancer Breast Cancer Ovarian Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics, Cold Genesys
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Oncolytic Virus Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncolytic Virus Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncolytic Virus Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Oncolytic Virus Therapy Market growing?

Ans: The Oncolytic Virus Therapy Market witnessing a CAGR of 24.9 during the forecast period 2024-2030.

What is the Oncolytic Virus Therapy Market size in 2030?

Ans: The Oncolytic Virus Therapy Market size in 2030 will be US$ 29 million.

What is the Amgen share in Oncolytic Virus Therapy Market?

Ans: Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.

Who are the main players in the Oncolytic Virus Therapy Market report?

Ans: The main players in the Oncolytic Virus Therapy Market are Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics, Cold Genesys

What are the Application segmentation covered in the Oncolytic Virus Therapy Market report?

Ans: The Applications covered in the Oncolytic Virus Therapy Market report are Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Others

What are the Type segmentation covered in the Oncolytic Virus Therapy Market report?

Ans: The Types covered in the Oncolytic Virus Therapy Market report are HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses, Vaccinia Virus-based Oncolytic Viruses, Vesicular Stomatitis Virus-based Oncolytic Viruses, Newcastle Disease Virus-based Oncolytic Viruses

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oncolytic Virus Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 HSV-based Oncolytic Viruses

1.2.3 Adenoviruses-based Oncolytic Viruses

1.2.4 Vaccinia Virus-based Oncolytic Viruses

1.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses

1.2.6 Newcastle Disease Virus-based Oncolytic Viruses

1.3 Market by Application

1.3.1 Global Oncolytic Virus Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Melanoma

1.3.3 Prostate Cancer

1.3.4 Breast Cancer

1.3.5 Ovarian Cancer

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oncolytic Virus Therapy Market Perspective (2019-2030)

2.2 Global Oncolytic Virus Therapy Growth Trends by Region

2.2.1 Oncolytic Virus Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Oncolytic Virus Therapy Historic Market Size by Region (2019-2024)

2.2.3 Oncolytic Virus Therapy Forecasted Market Size by Region (2025-2030)

2.3 Oncolytic Virus Therapy Market Dynamics

2.3.1 Oncolytic Virus Therapy Industry Trends

2.3.2 Oncolytic Virus Therapy Market Drivers

2.3.3 Oncolytic Virus Therapy Market Challenges

2.3.4 Oncolytic Virus Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Oncolytic Virus Therapy by Players

3.1.1 Global Oncolytic Virus Therapy Revenue by Players (2019-2024)

3.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Oncolytic Virus Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Oncolytic Virus Therapy Market Concentration Ratio

3.4.1 Global Oncolytic Virus Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Therapy Revenue in 2023

3.5 Global Key Players of Oncolytic Virus Therapy Head office and Area Served

3.6 Global Key Players of Oncolytic Virus Therapy, Product and Application

3.7 Global Key Players of Oncolytic Virus Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oncolytic Virus Therapy Breakdown Data by Type

4.1 Global Oncolytic Virus Therapy Historic Market Size by Type (2019-2024)

4.2 Global Oncolytic Virus Therapy Forecasted Market Size by Type (2025-2030)

5 Oncolytic Virus Therapy Breakdown Data by Application

5.1 Global Oncolytic Virus Therapy Historic Market Size by Application (2019-2024)

5.2 Global Oncolytic Virus Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Oncolytic Virus Therapy Market Size (2019-2030)

6.2 North America Oncolytic Virus Therapy Market Size by Type

6.2.1 North America Oncolytic Virus Therapy Market Size by Type (2019-2024)

6.2.2 North America Oncolytic Virus Therapy Market Size by Type (2025-2030)

6.2.3 North America Oncolytic Virus Therapy Market Share by Type (2019-2030)

6.3 North America Oncolytic Virus Therapy Market Size by Application

6.3.1 North America Oncolytic Virus Therapy Market Size by Application (2019-2024)

6.3.2 North America Oncolytic Virus Therapy Market Size by Application (2025-2030)

6.3.3 North America Oncolytic Virus Therapy Market Share by Application (2019-2030)

6.4 North America Oncolytic Virus Therapy Market Size by Country

6.4.1 North America Oncolytic Virus Therapy Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Oncolytic Virus Therapy Market Size by Country (2019-2024)

6.4.3 North America Oncolytic Virus Therapy Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Oncolytic Virus Therapy Market Size (2019-2030)

7.2 Europe Oncolytic Virus Therapy Market Size by Type

7.2.1 Europe Oncolytic Virus Therapy Market Size by Type (2019-2024)

7.2.2 Europe Oncolytic Virus Therapy Market Size by Type (2025-2030)

7.2.3 Europe Oncolytic Virus Therapy Market Share by Type (2019-2030)

7.3 Europe Oncolytic Virus Therapy Market Size by Application

7.3.1 Europe Oncolytic Virus Therapy Market Size by Application (2019-2024)

7.3.2 Europe Oncolytic Virus Therapy Market Size by Application (2025-2030)

7.3.3 Europe Oncolytic Virus Therapy Market Share by Application (2019-2030)

7.4 Europe Oncolytic Virus Therapy Market Size by Country

7.4.1 Europe Oncolytic Virus Therapy Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Oncolytic Virus Therapy Market Size by Country (2019-2024)

7.4.3 Europe Oncolytic Virus Therapy Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Oncolytic Virus Therapy Market Size (2019-2030)

8.2 China Oncolytic Virus Therapy Market Size by Type

8.2.1 China Oncolytic Virus Therapy Market Size by Type (2019-2024)

8.2.2 China Oncolytic Virus Therapy Market Size by Type (2025-2030)

8.2.3 China Oncolytic Virus Therapy Market Share by Type (2019-2030)

8.3 China Oncolytic Virus Therapy Market Size by Application

8.3.1 China Oncolytic Virus Therapy Market Size by Application (2019-2024)

8.3.2 China Oncolytic Virus Therapy Market Size by Application (2025-2030)

8.3.3 China Oncolytic Virus Therapy Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Oncolytic Virus Therapy Market Size (2019-2030)

9.2 Asia Oncolytic Virus Therapy Market Size by Type

9.2.1 Asia Oncolytic Virus Therapy Market Size by Type (2019-2024)

9.2.2 Asia Oncolytic Virus Therapy Market Size by Type (2025-2030)

9.2.3 Asia Oncolytic Virus Therapy Market Share by Type (2019-2030)

9.3 Asia Oncolytic Virus Therapy Market Size by Application

9.3.1 Asia Oncolytic Virus Therapy Market Size by Application (2019-2024)

9.3.2 Asia Oncolytic Virus Therapy Market Size by Application (2025-2030)

9.3.3 Asia Oncolytic Virus Therapy Market Share by Application (2019-2030)

9.4 Asia Oncolytic Virus Therapy Market Size by Region

9.4.1 Asia Oncolytic Virus Therapy Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Oncolytic Virus Therapy Market Size by Region (2019-2024)

9.4.3 Asia Oncolytic Virus Therapy Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Size by Type

10.2.1 Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Size by Application

10.3.1 Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Size by Country

10.4.1 Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Details

11.1.2 Amgen Business Overview

11.1.3 Amgen Oncolytic Virus Therapy Introduction

11.1.4 Amgen Revenue in Oncolytic Virus Therapy Business (2019-2024)

11.1.5 Amgen Recent Developments

11.2 Oncolytics Biotech

11.2.1 Oncolytics Biotech Company Details

11.2.2 Oncolytics Biotech Business Overview

11.2.3 Oncolytics Biotech Oncolytic Virus Therapy Introduction

11.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2019-2024)

11.2.5 Oncolytics Biotech Recent Developments

11.3 Viralytics

11.3.1 Viralytics Company Details

11.3.2 Viralytics Business Overview

11.3.3 Viralytics Oncolytic Virus Therapy Introduction

11.3.4 Viralytics Revenue in Oncolytic Virus Therapy Business (2019-2024)

11.3.5 Viralytics Recent Developments

11.4 Transgene SA

11.4.1 Transgene SA Company Details

11.4.2 Transgene SA Business Overview

11.4.3 Transgene SA Oncolytic Virus Therapy Introduction

11.4.4 Transgene SA Revenue in Oncolytic Virus Therapy Business (2019-2024)

11.4.5 Transgene SA Recent Developments

11.5 Oncolys BioPharma

11.5.1 Oncolys BioPharma Company Details

11.5.2 Oncolys BioPharma Business Overview

11.5.3 Oncolys BioPharma Oncolytic Virus Therapy Introduction

11.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2019-2024)

11.5.5 Oncolys BioPharma Recent Developments

11.6 Targovax

11.6.1 Targovax Company Details

11.6.2 Targovax Business Overview

11.6.3 Targovax Oncolytic Virus Therapy Introduction

11.6.4 Targovax Revenue in Oncolytic Virus Therapy Business (2019-2024)

11.6.5 Targovax Recent Developments

11.7 PsiOxus Therapeutics

11.7.1 PsiOxus Therapeutics Company Details

11.7.2 PsiOxus Therapeutics Business Overview

11.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Introduction

11.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)

11.7.5 PsiOxus Therapeutics Recent Developments

11.8 SillaJen Biotherapeutics

11.8.1 SillaJen Biotherapeutics Company Details

11.8.2 SillaJen Biotherapeutics Business Overview

11.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Introduction

11.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)

11.8.5 SillaJen Biotherapeutics Recent Developments

11.9 Sorrento Therapeutics

11.9.1 Sorrento Therapeutics Company Details

11.9.2 Sorrento Therapeutics Business Overview

11.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Introduction

11.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)

11.9.5 Sorrento Therapeutics Recent Developments

11.10 Lokon Pharma

11.10.1 Lokon Pharma Company Details

11.10.2 Lokon Pharma Business Overview

11.10.3 Lokon Pharma Oncolytic Virus Therapy Introduction

11.10.4 Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2019-2024)

11.10.5 Lokon Pharma Recent Developments

11.11 Genelux Corporation

11.11.1 Genelux Corporation Company Details

11.11.2 Genelux Corporation Business Overview

11.11.3 Genelux Corporation Oncolytic Virus Therapy Introduction

11.11.4 Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2019-2024)

11.11.5 Genelux Corporation Recent Developments

11.12 Vyriad

11.12.1 Vyriad Company Details

11.12.2 Vyriad Business Overview

11.12.3 Vyriad Oncolytic Virus Therapy Introduction

11.12.4 Vyriad Revenue in Oncolytic Virus Therapy Business (2019-2024)

11.12.5 Vyriad Recent Developments

11.13 TILT Biotherapeutics

11.13.1 TILT Biotherapeutics Company Details

11.13.2 TILT Biotherapeutics Business Overview

11.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Introduction

11.13.4 TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)

11.13.5 TILT Biotherapeutics Recent Developments

11.14 Cold Genesys

11.14.1 Cold Genesys Company Details

11.14.2 Cold Genesys Business Overview

11.14.3 Cold Genesys Oncolytic Virus Therapy Introduction

11.14.4 Cold Genesys Revenue in Oncolytic Virus Therapy Business (2019-2024)

11.14.5 Cold Genesys Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

SillaJen Biotherapeutics

Sorrento Therapeutics

List of Tables

Table 1. Global Oncolytic Virus Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of HSV-based Oncolytic Viruses

Table 3. Key Players of Adenoviruses-based Oncolytic Viruses

Table 4. Key Players of Vaccinia Virus-based Oncolytic Viruses

Table 5. Key Players of Vesicular Stomatitis Virus-based Oncolytic Viruses

Table 6. Key Players of Newcastle Disease Virus-based Oncolytic Viruses

Table 7. Global Oncolytic Virus Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 8. Global Oncolytic Virus Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Oncolytic Virus Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Oncolytic Virus Therapy Market Share by Region (2019-2024)

Table 11. Global Oncolytic Virus Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Oncolytic Virus Therapy Market Share by Region (2025-2030)

Table 13. Oncolytic Virus Therapy Market Trends

Table 14. Oncolytic Virus Therapy Market Drivers

Table 15. Oncolytic Virus Therapy Market Challenges

Table 16. Oncolytic Virus Therapy Market Restraints

Table 17. Global Oncolytic Virus Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Oncolytic Virus Therapy Revenue Share by Players (2019-2024)

Table 19. Global Top Oncolytic Virus Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2023)

Table 20. Global Oncolytic Virus Therapy Industry Ranking 2022 VS 2023 VS 2024

Table 21. Global 5 Largest Players Market Share by Oncolytic Virus Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Oncolytic Virus Therapy, Headquarters and Area Served

Table 23. Global Key Players of Oncolytic Virus Therapy, Product and Application

Table 24. Global Key Players of Oncolytic Virus Therapy, Product and Application

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Oncolytic Virus Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Oncolytic Virus Therapy Revenue Market Share by Type (2019-2024)

Table 28. Global Oncolytic Virus Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Oncolytic Virus Therapy Revenue Market Share by Type (2025-2030)

Table 30. Global Oncolytic Virus Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Oncolytic Virus Therapy Revenue Share by Application (2019-2024)

Table 32. Global Oncolytic Virus Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Oncolytic Virus Therapy Revenue Share by Application (2025-2030)

Table 34. North America Oncolytic Virus Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 35. North America Oncolytic Virus Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 36. North America Oncolytic Virus Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 37. North America Oncolytic Virus Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 38. North America Oncolytic Virus Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Oncolytic Virus Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Oncolytic Virus Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Oncolytic Virus Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 42. Europe Oncolytic Virus Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 43. Europe Oncolytic Virus Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 44. Europe Oncolytic Virus Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 45. Europe Oncolytic Virus Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Europe Oncolytic Virus Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 47. Europe Oncolytic Virus Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 48. China Oncolytic Virus Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 49. China Oncolytic Virus Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 50. China Oncolytic Virus Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 51. China Oncolytic Virus Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 52. Asia Oncolytic Virus Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 53. Asia Oncolytic Virus Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 54. Asia Oncolytic Virus Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 55. Asia Oncolytic Virus Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 56. Asia Oncolytic Virus Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 57. Asia Oncolytic Virus Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 58. Asia Oncolytic Virus Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Oncolytic Virus Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 64. Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 66. Amgen Company Details

Table 67. Amgen Business Overview

Table 68. Amgen Oncolytic Virus Therapy Product

Table 69. Amgen Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)

Table 70. Amgen Recent Developments

Table 71. Oncolytics Biotech Company Details

Table 72. Oncolytics Biotech Business Overview

Table 73. Oncolytics Biotech Oncolytic Virus Therapy Product

Table 74. Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)

Table 75. Oncolytics Biotech Recent Developments

Table 76. Viralytics Company Details

Table 77. Viralytics Business Overview

Table 78. Viralytics Oncolytic Virus Therapy Product

Table 79. Viralytics Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)

Table 80. Viralytics Recent Developments

Table 81. Transgene SA Company Details

Table 82. Transgene SA Business Overview

Table 83. Transgene SA Oncolytic Virus Therapy Product

Table 84. Transgene SA Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)

Table 85. Transgene SA Recent Developments

Table 86. Oncolys BioPharma Company Details

Table 87. Oncolys BioPharma Business Overview

Table 88. Oncolys BioPharma Oncolytic Virus Therapy Product

Table 89. Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)

Table 90. Oncolys BioPharma Recent Developments

Table 91. Targovax Company Details

Table 92. Targovax Business Overview

Table 93. Targovax Oncolytic Virus Therapy Product

Table 94. Targovax Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)

Table 95. Targovax Recent Developments

Table 96. PsiOxus Therapeutics Company Details

Table 97. PsiOxus Therapeutics Business Overview

Table 98. PsiOxus Therapeutics Oncolytic Virus Therapy Product

Table 99. PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)

Table 100. PsiOxus Therapeutics Recent Developments

Table 101. SillaJen Biotherapeutics Company Details

Table 102. SillaJen Biotherapeutics Business Overview

Table 103. SillaJen Biotherapeutics Oncolytic Virus Therapy Product

Table 104. SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)

Table 105. SillaJen Biotherapeutics Recent Developments

Table 106. Sorrento Therapeutics Company Details

Table 107. Sorrento Therapeutics Business Overview

Table 108. Sorrento Therapeutics Oncolytic Virus Therapy Product

Table 109. Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)

Table 110. Sorrento Therapeutics Recent Developments

Table 111. Lokon Pharma Company Details

Table 112. Lokon Pharma Business Overview

Table 113. Lokon Pharma Oncolytic Virus Therapy Product

Table 114. Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)

Table 115. Lokon Pharma Recent Developments

Table 116. Genelux Corporation Company Details

Table 117. Genelux Corporation Business Overview

Table 118. Genelux Corporation Oncolytic Virus Therapy Product

Table 119. Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)

Table 120. Genelux Corporation Recent Developments

Table 121. Vyriad Company Details

Table 122. Vyriad Business Overview

Table 123. Vyriad Oncolytic Virus Therapy Product

Table 124. Vyriad Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)

Table 125. Vyriad Recent Developments

Table 126. TILT Biotherapeutics Company Details

Table 127. TILT Biotherapeutics Business Overview

Table 128. TILT Biotherapeutics Oncolytic Virus Therapy Product

Table 129. TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)

Table 130. TILT Biotherapeutics Recent Developments

Table 131. Cold Genesys Company Details

Table 132. Cold Genesys Business Overview

Table 133. Cold Genesys Oncolytic Virus Therapy Product

Table 134. Cold Genesys Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)

Table 135. Cold Genesys Recent Developments

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Oncolytic Virus Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Oncolytic Virus Therapy Market Share by Type: 2023 VS 2030

Figure 3. HSV-based Oncolytic Viruses Features

Figure 4. Adenoviruses-based Oncolytic Viruses Features

Figure 5. Vaccinia Virus-based Oncolytic Viruses Features

Figure 6. Vesicular Stomatitis Virus-based Oncolytic Viruses Features

Figure 7. Newcastle Disease Virus-based Oncolytic Viruses Features

Figure 8. Global Oncolytic Virus Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Oncolytic Virus Therapy Market Share by Application: 2023 VS 2030

Figure 10. Melanoma Case Studies

Figure 11. Prostate Cancer Case Studies

Figure 12. Breast Cancer Case Studies

Figure 13. Ovarian Cancer Case Studies

Figure 14. Others Case Studies

Figure 15. Oncolytic Virus Therapy Report Years Considered

Figure 16. Global Oncolytic Virus Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Oncolytic Virus Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Oncolytic Virus Therapy Market Share by Region: 2023 VS 2030

Figure 19. Global Oncolytic Virus Therapy Market Share by Players in 2023

Figure 20. Global Top Oncolytic Virus Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Oncolytic Virus Therapy Revenue in 2023

Figure 22. North America Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Oncolytic Virus Therapy Market Share by Type (2019-2030)

Figure 24. North America Oncolytic Virus Therapy Market Share by Application (2019-2030)

Figure 25. North America Oncolytic Virus Therapy Market Share by Country (2019-2030)

Figure 26. United States Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Canada Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Oncolytic Virus Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 29. Europe Oncolytic Virus Therapy Market Share by Type (2019-2030)

Figure 30. Europe Oncolytic Virus Therapy Market Share by Application (2019-2030)

Figure 31. Europe Oncolytic Virus Therapy Market Share by Country (2019-2030)

Figure 32. Germany Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. France Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. U.K. Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Italy Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Russia Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Nordic Countries Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. China Oncolytic Virus Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 39. China Oncolytic Virus Therapy Market Share by Type (2019-2030)

Figure 40. China Oncolytic Virus Therapy Market Share by Application (2019-2030)

Figure 41. Asia Oncolytic Virus Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 42. Asia Oncolytic Virus Therapy Market Share by Type (2019-2030)

Figure 43. Asia Oncolytic Virus Therapy Market Share by Application (2019-2030)

Figure 44. Asia Oncolytic Virus Therapy Market Share by Region (2019-2030)

Figure 45. Japan Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. South Korea Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. China Taiwan Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Southeast Asia Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. India Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Australia Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 52. Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Share by Type (2019-2030)

Figure 53. Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Share by Application (2019-2030)

Figure 54. Middle East, Africa, and Latin America Oncolytic Virus Therapy Market Share by Country (2019-2030)

Figure 55. Brazil Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Mexico Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Turkey Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Saudi Arabia Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Israel Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. GCC Countries Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 61. Amgen Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)

Figure 62. Oncolytics Biotech Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)

Figure 63. Viralytics Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)

Figure 64. Transgene SA Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)

Figure 65. Oncolys BioPharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)

Figure 66. Targovax Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)

Figure 67. PsiOxus Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)

Figure 68. SillaJen Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)

Figure 69. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)

Figure 70. Lokon Pharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)

Figure 71. Genelux Corporation Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)

Figure 72. Vyriad Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)

Figure 73. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)

Figure 74. Cold Genesys Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)

Figure 75. Bottom-up and Top-down Approaches for This Report

Figure 76. Data Triangulation

Figure 77. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions